Skip to main content

Zusammenfassung

Autoimmunerkrankungen stellen eine heterogene Gruppe von 70–80 verschiedenen entzundlichen Erkrankungen dar, die ca. 4–10% der Bevolkerung betreff en (Shapira et al. 2009). Kosten fur Autoimmunerkrankungen fur das Gesundheitswesen werden mittlerweile im Bereich von Herz-Kreislauf-Erkrankungen und Krebserkrankungen gesehen, insbesondere aufgrund des oft uber Jahrzehnte chronischen Verlaufs (Shapira et al. 2009). Daten sprechen fur einen Anstieg der Inzidenz und Pravalenz in den Industrienationen (Shapira et al. 2009). Autoimmunerkrankungen lassen sich nachweisen auf der Basis einer Immunantwort, die sich gegen Gewebe richtet. Diese lassen sich nach dem Zielorgan, dem Zielgewebe oder Funktionssystem gegen den sich die Immunreaktivitat richtet klassifizieren. Autoimmunerkrankungen konnen fruh bis zur 2. Dekade auft reten, z. B. Diabetes mellitus Typ 1, lassen sich jedoch typischerweise in der 3. bis 6. Dekade diagnostizieren. Die Atiopathogenese von Autoimmunerkrankungen ist komplex. Im Vordergrund stehen genetische, immunologische, endokrine und Umweltfaktoren. Fur wesentliche Autoimmunerkrankungen wie Diabetes mellitus Typ 1, multiple Sklerose (MS), autoimmune Schilddrusenerkrankungen und entzundliche Darmerkrankungen lasst sich eine Haufung in gema.igten Breiten und damit in hochentwickelten Industrienationen nachweisen. Bei den Umweltfaktoren werden im Wesentlichen UV-Strahlungen, westlicher Lebensstil, Infektionen, Umweltgift e, Ernahrungsfaktoren und einige krankheitsspezifische Faktoren wie z. B. Jodexposition bei Autoimmunthyreoiditis diskutiert. Die Th erapien sind oft teilwirksam, palliativ, die Lebensqualitat ist oft erheblich eingeschrankt. Damit haben Autoimmunerkrankungen eine hohe personliche und okonomische Relevanz. Vor dem Hintergrund, dass 80% der Autoimmunerkrankungen bei Frauen auft reten, sind schon epidemiologisch endokrine Faktoren in der Pathogenese hochwahrscheinlich. Eine grundsatzlich unterschiedliche immunologische Antwort auf inflammatorische Stimuli zwischen Mannern und Frauen konnte hier relevant sein. Bei Frauen kommt es verstarkt zu einer Antikorperantwort, bei Mannern eher zu einer allgemeinen inflammatorischen Reaktion. So finden sich z. B. Unterschiede in der Interferon-Gamma-Antwort auf Stressreize (Cutolo u. Straub 2009).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ader R, Cohen N (1975) Behaviorally conditioned immunosuppression. Psychosom Med 37(4): 333–340

    CAS  PubMed  Google Scholar 

  • Anonymous (2009) What is health? The ability to adapt. Lancet 373(9666): 781

    Article  Google Scholar 

  • Bagnasco M, Bossert I, Pesce G (2006) Stress and autoimmune thyroid diseases. Neuroimmunomodulaton 13(5-6): 309– 17

    Article  CAS  Google Scholar 

  • Bettini M, Vignali DA (2009) Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21(6): 612–618

    Article  CAS  PubMed  Google Scholar 

  • Bricou O, Taïeb O, Baubet T, Gal B, Guillevin L, Moro MR (2006) Stress and coping strategies in systemic lupus erythematosus: a review. Neuroimmunomodulation 13(5–6): 283– 293

    Article  CAS  PubMed  Google Scholar 

  • Buttgereit F, Doering G, Schaeffler A et al. (2008) Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 371(9608): 205–214

    Article  CAS  PubMed  Google Scholar 

  • Calcagni E, Elenkov I (2006) Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann NY Acad Sci 1069: 62–76

    Article  CAS  PubMed  Google Scholar 

  • Cámara RJ, Ziegler R, Begré S, Schoepfer AM, von Känel R (2009) Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) group. The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion 80(2): 129–139

    Article  PubMed  Google Scholar 

  • Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648): 1502–1517

    Article  CAS  PubMed  Google Scholar 

  • Cutolo M (2010) Hormone therapy in rheumatic diseases. Curr Opin Rheumatol. (Epub im Druck)

    Google Scholar 

  • Cutolo M, Straub RH (2009) Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther 11(2): 218

    Article  PubMed  Google Scholar 

  • De Keyser J, Zeinstra E, Mostert J, Wilczak N (2004) Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis. Trends Pharmacol Sci 25: 67–71

    Article  PubMed  Google Scholar 

  • Dube SR, Fairweather D, Pearson WS, Felitti VJ, Anda RF, Croft JB (2009) Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med 71(2): 243–250

    Article  PubMed  Google Scholar 

  • Elenkov IJ, Chrousos GP (2006) Stress system-organization, physiology and immunoregulation. Neuroimmunomodulation 13(5–6): 257–267

    Article  CAS  PubMed  Google Scholar 

  • Flachenecker P, Reiners RH., Krauser M, Wolf A, Toyka KV (2001). Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7: 327–324

    CAS  PubMed  Google Scholar 

  • Giang DW, Goodman AD, Schiffer RB, Mattson DH, Petrie M, Cohen N, Ader R (1996) Conditioning of cyclophosphamide- induced leukopenia in humans. J Neuropsychiatry Clin Neurosci 8: 194–201

    CAS  PubMed  Google Scholar 

  • Giorelli M, Livrea P, Trojano M (2004). Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients. J Neuroimmunol. 155:143–149

    Article  CAS  PubMed  Google Scholar 

  • Glass-Marmor L, Paperna T, Ben-Yosef Y, Miller A (2007) Chronotherapy using corticosteroids for multiple sclerosis relapses. J Neurol Neurosurg Psychiatry 78(8): 886–888

    Article  PubMed  Google Scholar 

  • Golan D, Somer E, Dishon S, Cuzin-Disegni L, Miller A (2008) Impact of exposure to war stress on exacerbations of multiple sclerosis. Ann Neurol 64(2): 143–148

    Article  PubMed  Google Scholar 

  • Gold SM, Voskuhl RR (2009) Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 175: 239–251

    Article  CAS  PubMed  Google Scholar 

  • Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C (2005) The role of stress-response systems for the pathogenesis and progression of multiple sclerosis. Trends Immunol 6: 644–651

    Article  Google Scholar 

  • Gold SM, Chalifoux S, Giesser BS, Voskuhl RR (2008) Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone. J Neuroinflammation 5: 32

    Article  PubMed  Google Scholar 

  • Heesen C, Romberg A, Gold S, Schulz KH (2006) Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment. Expert Rev Neurother 6(3): 347–355

    Article  PubMed  Google Scholar 

  • Heesen C, Gold SM, Huitinga I, Reul JMHM (2007) Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review. Psychneuroendocrinology 32(6): 604–618

    Article  CAS  Google Scholar 

  • Horneff G (2006) Ätiopathogenese de systemischen Lupus erythematodes. Monatsschr Kinderheil 154: 1177–1188

    Article  Google Scholar 

  • Jacobs R, Pawlak CR, Mikeska E et al. (2001) Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford) 40(8): 868–875

    Article  CAS  Google Scholar 

  • Klareskog L, Widhe M, Hermansson M, Rönnelid J (2008) Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr Opin Rheumatol 20(3): 300–305

    Article  CAS  PubMed  Google Scholar 

  • Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G (2008) Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 15(1): 68–75

    CAS  PubMed  Google Scholar 

  • Knip M, Siljander H Autoimmune mechanisms in type 1 diabetes (2008) Autoimmun Rev 7(7): 550–557

    Google Scholar 

  • Köpke S, Kasper J, Mühlhauser I, Nübling M, Heesen C (2009) Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized- controlled trial. Mult Scler 15(1): 96–104

    Article  PubMed  Google Scholar 

  • Kunz M, Ibrahim SM (2009) Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009: 979258

    Google Scholar 

  • Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J (2004) The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark. Neurology 62(5): 726–729

    CAS  PubMed  Google Scholar 

  • Liao KP, Alfredsson L, Karlson EW (2009) Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 21(3): 279–283

    Article  PubMed  Google Scholar 

  • Margolis KG, Gershon MD (2009) Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol 25(6): 503–511

    Article  CAS  PubMed  Google Scholar 

  • Mason D. (1991) Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 12(2): 57–60

    Article  CAS  PubMed  Google Scholar 

  • Mawdsley JE, Rampton DS (2006) The role of psychological stress in inflammatory bowel disease. Neuroimmunomodulation 13(5–6): 327–336

    Article  CAS  PubMed  Google Scholar 

  • Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004). Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328: 731–735

    Article  PubMed  Google Scholar 

  • Pawlak CR, Jacobs R, Mikeska E et al. (1999) Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress. Brain Behav Immun 13(4): 287–302

    Article  CAS  PubMed  Google Scholar 

  • Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47(6): 920–923

    Article  CAS  Google Scholar 

  • Sakić B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA (1994) Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 56(3): 609–617

    Article  PubMed  Google Scholar 

  • Scaldaferri F, Fiocchi C (2007) Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 8(4): 171–178

    Article  CAS  PubMed  Google Scholar 

  • Selmi C (2009) A new year in autoimmunity. Ann NY Acad Sci 1173: 239–242, Review

    Google Scholar 

  • Sepa A, Ludvigsson J (2006) Psychological stress and the risk of diabetes-related autoimmunity: a review article. Neuroimmunomodulation 13(5–6): 301–308

    Article  CAS  PubMed  Google Scholar 

  • Shapira Y, Agmon-Levin N, Shoenfeld Y (2009) Defining and analyzing geoepidemiology and human autoimmunity. (Epub im Druck)

    Google Scholar 

  • Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Annals of Neurology Oct;52(4):421–428

    Google Scholar 

  • Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res. 1992 Jan 20;570(1–2):54–60

    Google Scholar 

  • Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J (2002) Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J Neuroimmunol 126(1–2): 116–125

    Article  CAS  PubMed  Google Scholar 

  • Straub RH, Dhabhar FS, Bijlsma JW, Cutolo M (2005) How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum 52(1): 16–26

    Article  PubMed  Google Scholar 

  • Straub HR, del Rey A, Besedovsky H (2007) Konzept zur Erklärung ähnlicher pathophysiologischer Mechanismen bei verschiedenen Krankheiten unter Berücksichtigung der biologischen Evulotion. In: Straub RH (Hrsg) Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen. Band 2: Spe. Pathophysiologie. Vandenhoek & Ruprecht, Göttingen, S 9–22

    Google Scholar 

  • Straub RH, Rauch L, Fassold A, Lowin T, Pongratz G (2008) Neuronally released sympathetic neurotransmitters stimulate splenic interferon-gamma secretion from T cells in early type II collagen-induced arthritis. Arthritis Rheum 58(11): 3450–3460

    Article  CAS  PubMed  Google Scholar 

  • van Winsen LM, Polman CH, Dijkstra CD, Tilders FJ, Uitdehaag BM (2010) Suppressive effect of glucocorticoids on TNFalpha production is associated with their clinical effect in multiple sclerosis. Mult Scler 16(4): 500–502

    Article  PubMed  Google Scholar 

  • Voskuhl RR (2003) Hormone-based therapie in MS. Int MS J 10: 60–66

    CAS  PubMed  Google Scholar 

  • Weidler C, Holzer C, Harbuz M, Hofbauer R, Angele P, Schölmerich J, Straub RH (2005) Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Annals of the Rheumatic Diseases 64(1):13–20

    Article  CAS  PubMed  Google Scholar 

  • Wick G, Hu Y, Gruber J, Kühr T, Wozak E, Hála K (1992) The role of modulatory factors in the multifacetted pathogenesis of autoimmune thyroiditis. Int Rev Immunol 9(2): 77–89

    Article  CAS  PubMed  Google Scholar 

  • Ysrraelit MC, Gaitán MI, Lopez AS, Correale J (2008) Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 71(24): 1948–1954

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Heesen, C., Gold, S.M. (2011). Autoimmunerkrankungen. In: Ehlert, U., von Känel, R. (eds) Psychoendokrinologie und Psychoimmunologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16964-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16964-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16963-2

  • Online ISBN: 978-3-642-16964-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics